Introduction {#Sec1}
============

The Phage shock protein (Psp) response was discovered during studies of the infection process of filamentous phage f1 in *Escherichia coli*, where Psp proteins were induced by production of the phage-derived secretin pIV \[[@CR7]\]. Since then, substantial progress has been made in understanding the physiological role of the Psp response. It is now clear that it is not only important during f1-phage infection, but also generally helps the bacterium to respond to stresses that impair the inner membrane integrity. Psp proteins function to maintain the proton motive force (PMF) under otherwise PMF-dissipating conditions \[[@CR25], [@CR29], [@CR30]\]. The Psp response is important for the pathogenicity of enterobacteria such as *Salmonella enterica* \[[@CR17]\] or *Shigella flexneri*. Furthermore it is involved in biofilm formation of *E. coli* \[[@CR5]\] and in bacterial protein secretion \[[@CR24]\] and translocation \[[@CR9], [@CR10], [@CR23], [@CR37]\]. The importance of Psp proteins is not limited to proteobacteria. PspA homologues have been found in the cyanobacterium *Synechocystis* and in plants (where it is essential for thylakoid biogenesis and photosynthesis) \[[@CR45]\], as well as in Gram-positive bacteria and archaea \[[@CR6], [@CR42]\].

Despite detailed data regarding the mechanism of transcriptional regulation of the Psp response \[[@CR8]--[@CR10], [@CR12], [@CR13], [@CR22], [@CR23], [@CR31], [@CR34], [@CR46]\], important information explaining its onset still remains elusive. The authors recently reported direct cross-talk, via protein--protein interactions, between the ArcAB and Psp systems \[[@CR26]\]. It was revealed that in microaerobiosis activation of ArcB and the subsequent phosphorelay to its response regulator ArcA are required for the full expression of the *psp* genes \[[@CR25], [@CR26]\]. The ArcAB system consequently appears to be important for the creation or amplification of one *psp*-inducing signal. However, it is not clear whether the ArcAB effect on *psp* expression is due to direct ArcB activation of *psp* or due to a physiological consequence of an ArcB dependent activation of other factors.

The findings from Jovanovic et al*.* \[[@CR25], [@CR26]\] imply that an inducing signal may be sensed by the ArcB sensor kinase. The kinase activity of ArcB is regulated in part through the redox state of the quinone pools \[[@CR4], [@CR19], [@CR32]\]. The quinone pool may therefore be a component of the *psp* signalling cascade acting upstream of ArcB. However, the nature of the signals for the *psp* induction is still unknown, although it is often proposed that *psp* is induced by dissipation of PMF \[[@CR9], [@CR34]\].

In this study, the authors have specifically analysed the two PMF components---the H^+^-gradient and the electrical potential---as well as the cellular quinone pool for their roles in the induction of the Psp response. It was demonstrated that neither loss of the H^+^-gradient nor dissipation of the electrical potential is sufficient to induce *psp*. Further, pIV-dependent induction of *psp* occurs when the redox state of the quinone pool becomes less reduced, suggesting the physiological signal---whilst being linked to ArcAB---is not a reduced redox state of quinones.

Materials and Methods {#Sec2}
=====================

Bacterial Strains, Media and Growth Conditions {#Sec3}
----------------------------------------------

Bacterial strains and plasmids are shown in Table [1](#Tab1){ref-type="table"}. The bacteriophage P1~*vir*~ general-transduction method as described by Miller \[[@CR33]\] was used to introduce a *lacZ* transcriptional reporter fusion into the chromosome to create EC10-13 and to transfer the *menA* mutation from JW3901 \[[@CR28]\] into MVA4 to create EC14 (Table [1](#Tab1){ref-type="table"}). Strains were grown at 37°C in Luria--Bertani (LB) broth or on LB agar plates \[[@CR33]\] supplemented with the appropriate antibiotic(s). Depending on the desired level of aeration, a 30 ml culture of the strain to be tested (with an initial OD~600~ \~ 0.1) was grown in 250 ml (aerobic growth) or 100 ml (microaerobic growth) Erlenmeyer flasks at either 200 rpm (aerobic growth) or 100 rpm (microaerobic growth) \[[@CR26]\]. For anaerobic growth, strains were grown without shaking in a universal tube fully filled with culture and sealed with a Suba-seal^®^ (Sigma). Where indicated CCCP, Valinomycin and acetate were added at the following final concentrations: CCCP 40 μM, Valinomycin 10 μM (for K^+^-uptake, 150 mM KCl and 120 mM Tris was added to the bacterial culture prior to Valinomycin treatment) and acetate 34 mM. Experiments with 34 mM acetate were performed in LB supplemented with 50 mM MOPS (adjusted to pH 7.1--7.3) and LB supplemented with 100 mM MES (adjusted to pH 5.0). Growth rates of all strains tested were similar under the conditions used in this study.Table 1Strains and plasmidsStrain or plasmidRelevant characteristicsReferenceStrain BW25113F-, Δ*(araD-araB)567*, Δ*lacZ4787*(::rrnB-3), *&lambda*^*−*^, *rph-1*, Δ*(rhaD-rhaB)568*, *hsdR514*CGSC\# 7636 MC1061F-, Δ*(araA-leu)7697*, *\[araD139\]*~*B/r*~, Δ*(codB-lacI)3*, *galK16*, *galE15*(GalS), *&lambda*^*−*^, *e14-*, *mcrA0*, *relA1*, *rpsL150*(strR), *spoT1*, *mcrB1*, *hsdR2*CGSC\# 6649 MG1655F-, *lambda*^*−*^, *rph-1*CGSC\# 7740 RP437F-, *thr-1*, *araC14*, *leuB6*(Am), *fhuA31*, *lacY1*, *tsx-78*, *lambda*^*−*^, *eda-50*, *hisG4*(Oc), *rfbC1*?, *rpsL136*(strR), *xylA5*, *mtl-1*, *metF159*(Am), *thi-1*CGSC\# 12122 MG1655Δ*psp*FF-, *lambda*^−^, *rph*-1, Δ*psp*F\[[@CR30]\] MVA4MC1061ϕ*pspA*-*lacZ* (ap^r^)\[[@CR16]\] MVA44MG1655ϕ*pspA*-*lacZ* (ap^r^)\[[@CR25]\] MVA59MG1655Δ*arcB*::kan (kan^r^)\[[@CR25]\] BT3415RP437Δ*tsr*-*7021 nuoF*::miniTn*10*cm (cm^r^)\[[@CR14]\] BT3390RP437Δ*tsr*-*7021 ndh*:erm (erm^r^)\[[@CR14]\] BT3402BT3415Δ(*cyoABCDE*)*456*::kan (kan^r^)\[[@CR14]\] BT3406BT3390Δ(*cyoABCDE*)*456*::kan (kan^r^)\[[@CR14]\] BT3408BT3390 *Zbg*-*2200*::*kan*Δ(*cydAB′)455* (kan^r^)\[[@CR14]\] EC10RP437 ϕ*pspA*-*lacZ* (ap^r^) \[RP437×MVA4\]This study EC11RP437Δ*tsr*-*7021 nuoF*::miniTn*10*cm (cm^r^) Δ(*cyoABCDE*)*456*::kan (kan^r^) ϕ*pspA*-*lacZ* (ap^r^) \[BT3402×MVA4\]This study EC12RP437Δ*tsr*-*7021 ndh*:erm (erm^r^) Δ(*cyoABCDE*)*456*::kan (kan^r^) ϕ*pspA*-*lacZ* (ap^r^) \[BT3406×MVA4\]This study EC13RP437Δ*tsr*-*7021 ndh*:erm (erm^r^) *Zbg-2200*::*kan*Δ(*cydAB′*)*455* (kan^r^) ϕ*pspA*-*lacZ* (ap^r^) \[BT3408×MVA4\]This study JW3901BW25113Δ*menA*::kan (kan^r^)\[[@CR28]\] EC14MC1061ϕ *pspA-lacZ* Δ*menA:*:kan (kan^r^) \[MVA4×JW3901\]This studyPlasmids pGZ119EHIPTG-inducible *tac* promoter expression vector (cm^r^) ColD origin of replicationA gift from M. Russel pPMR129pGZ119EH harbouring *gIV* (pIV); ColD origin of replication; (cm^r^)A gift from M. Russel pGJ4IPTG-inducible P~*tac*~ promoter expression vector encoding *gIV* (pIV); ColD origin of replication; (tet^r^)\[[@CR25]\] pGJ46490 bp of *pflB* promoter region amplified by PCR from the chromosome of MG1655 and cloned into pRS415^A^ via *Eco*RI--*Bam*HI; p15A origin of replication; (ap^r^)\[[@CR26]\] pGJ66193 bp of *yfiD* promoter region amplified by PCR from the chromosome of MG1655 and cloned into pRS415^A^ via *Eco*RI--*Bam*HI; p15A origin of replication; (ap^r^)This studyListed are the strains and plasmids used in this study

Extraction and Measurement of Quinones {#Sec4}
--------------------------------------

The quinone extraction and measurement methodology was adapted from Bekker et al*.* \[[@CR3]\]. Cultures were grown to an OD~600~ \~ 1.0. Samples were taken during the exponential growth phase and cultures were not disturbed prior to sampling. To quench the sample, 8 ml of the culture were added quickly (to prevent reduction of the quinones; 3) to 24 ml of ice-cold methanol and the quinones extracted by adding 6 ml of petroleum ether (40--60°C) per 8 ml of MeOH-culture mixture. Samples were vortexed and centrifuged at 900×*g* for 2 min. The upper phase (petroleum ether) was removed into a clean tube and evaporated under constant nitrogen flow. The lower phase was again treated with 6 ml of petroleum ether, vortexed and centrifuged and the process repeated to back-extract any remaining quinones. The extracted and dried quinones were resuspended in 50 μl of 99.9% ethanol using a glass rod. A 30 μl sample of this solution was loaded onto a reverse phase Lichrosorb (Chrompack) 10 RP 18 column (4.6 mm i.d., 250 mm length) equilibrated with methanol which was also used as mobile phase. Quinone contents were analysed using the Pharmacia LKB gradient pump 2249 HPLC system. Peaks were identified by UV--Vis spectroscopy \[[@CR3]\] and the amount of quinones calculated from their corresponding area using a standard curve for UQ~10~ (Suppl. Fig. 5). Three separate growth/HPLC replicates were analysed per strain tested (Suppl. Fig. 6). In line with previous reports \[[@CR39], [@CR40], [@CR42], [@CR43], [@CR46]\] and as an internal control, MK~8~ and DMK~8~ could be detected under microaerobic growth conditions (Suppl. Fig. 6); under aerobic growth only ubiquinone and ubiquinol could be observed.

β-Galactosidase Assay {#Sec5}
---------------------

Cells were grown as specified above. The level of *pspA*, *pflB* and *yfiD* promoter activity was measured in three biological replicates for each strain tested. After determining the cell-density (by measuring the OD~600~), a 500 μl sample of the day-culture (at mid-log phase growth) was supplemented with 500 μl of Z buffer (60 mM Na~2~HPO~4~, 40 mM NaH~2~PO~4~, 10 mM KCl, 1 mM MgSO~4~ and 50 mM β-mercaptoethanol). Following addition of 50 μl of chloroform and vortexing for 30 s, the solution was incubated at 30°C with 200 μl of ONPG (4 mg/ml dissolved in Z buffer). The reaction was quenched by 500 μl of 1 M Na~2~CO~3~ once a pale yellow colour was observed and the time between addition of ONPG and quenching was recorded. The reaction was analysed at OD~420~ (ONPG hydrolysis) and OD~550~ (light scatter) and the activity of the *pspA*, *pflB* and *yfiD* promoter expressed as Miller units (MU).

Immunoblotting {#Sec6}
--------------

Immunoblotting was performed according to Elderkin et al. \[[@CR15]\] using PspA- or pIV-specific antibodies as indicated. Antibodies were used as follows: anti-PspA (This study; 1:1,000 overnight in 5% milk; secondary antibody: anti-rabbit-HRP 1:5,000 in 5% milk for 1 h), anti-pIV (a gift from M. Russel; 1:5,000 in 5% milk; secondary antibody: anti-rabbit-HRP 1:5,000 in 5% milk for 1 h).

Measurement of the Electrical Potential {#Sec7}
---------------------------------------

The electrical potential was measured via the membrane-permeable JC-1 dye \[[@CR2]\]. JC-1 changes its oligomeric state in response to the level of the electrical potential, forming red fluorescent J-aggregates (measured as red fluorescent emission at 590 nm upon excitation at 488 nm) if the cellular electrical potential is equal or greater than wild-type levels that is not stress challenged. When the electrical potential is decreased, JC-1 remains monomeric, emitting fluorescence at 530 nm (upon excitation at 488 nm). Cells with decreased electrical potential will therefore appear mostly green. Since conversion between both states is not 100%, cells with wild-type electrical potential will emit light at both wavelengths and hence simultaneously appear green and red. The electrical potential obtained using the JC-1 dye represents the cellular PMF since measurements were taken at pH 7.6 (corresponding to the pH inside the bacterial cell before permeabilisation). Cells were grown to mid-log phase in LB supplemented with the appropriate antibiotic(s). A 1 ml sample of cells was harvested (4,500×*g*) and resuspended in 1 ml of permeabilisation buffer (10 mM Tris--HCl (pH 7.6), 1 mM EDTA and 10 mM glucose). Following 30 min incubation with 2 μl JC-1 dye (5 mg/ml) (PIERCE) at RT, cells were harvested at 4,500×*g* and resuspended in 500 μl of permeabilisation buffer. Cells were imaged using a Leica SP2 upright confocal fluorescence microscope fitted with a HCX PL APO CS 63.0×1.32 Oil Ph3 objective and analysed using the LCS Lite software (Leica).

Results {#Sec8}
=======

The PMF-Dissipating Agents Valinomycin and Acetate do not Induce the Psp Response {#Sec9}
---------------------------------------------------------------------------------

It has been shown that CCCP dissipates the PMF and induces *psp* \[[@CR25]\] (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}). CCCP is a protonophore causing an influx of H^+^ into the cytoplasm, thereby discharging both the electrical potential and the H^+^-gradient across the inner membrane. Hence, it is conceivable that changes in one of the two PMF components may be required to trigger induction of the Psp response. The authors therefore tested the effect of both components on the *psp* induction individually (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}).Fig. 1Measurement of *psp* induction by various agents. **a** The *psp* induction was measured as LacZ activity in cells containing a chromosomal ϕ*pspA*--*lacZ* either in **a** MVA4 or **b**, **c** MVA44. **a***psp* is induced by CCCP (40 μM for 30 min; *Lane 2*) and pIV from pGJ4 (leaky expression, no addition of IPTG; *Lane 3* and *5*), but not by KCl/Tris (*Lane 4*), Valinomycin (10 μM for 30 min; *Lane 6*) or acetate (34 mM) at pH 5 (*Lane 7*) or pH 7 (data not shown). KCl/Tris does not inhibit the induction of *psp* by pIV (*Lane 5*). **b** The effect of Valinomycin on the ability of pIV to induce *psp* was assessed in MVA44 (MG1655ϕ*pspA*-*lacZ*) cells. Plasmid-borne pIV was set under the control of a tight IPTG-inducible promoter (pPMR129). All cells were incubated with 1 mM IPTG for 30 min. Cells in *lane 2* and *4* were treated with Valinomycin (10 μM for 30 min). IPTG and Valinomycin addition occurred simultaneously. IPTG treatment in cells containing pPMR129 induced the production of the pIV secretin (*Lane 3* and *4*). Note that the basal level of LacZ activity in MVA44 is increased compared to MVA4 due to the native *lacZ* located on the chromosome of MVA44. Expression of PspA protein was assessed by immunoblotting with PspA-specific antibodies. Cells in *lane 3* and *4* clearly show increased PspA production (due to the presence of pIV as determined by immunoblotting with pIV-specific antibodies). **c** To test, whether "time after stress" was important for induction of *psp* by Valinomycin, the LacZ activity in MVA44 was measured after 10 and 30 min incubation with Valinomycin (10 μM) and compared to untreated MVA44 cells. To cross-compare with results from **b** cells were incubated with 1 mM IPTG for the indicated length of time. Valinomycin does not induce *psp* after 10 and 30 min (*Lane 2* and *4*)Fig. 2PMF measurement in MG1655 cells. The PMF in MG1655 was measured at mid-log phase growth using the JC-1 dye. Cells were either untreated (*MG1655*~*WT*~), or grown in the presence of pIV from pGJ4 (leaky expression, no addition of IPTG) (*MG1655* *+* *pIV*), CCCP (40 μM for 30 min; *MG1655* *+* *CCCP*), Valinomycin (10 μM for 30 min; *MG1655* *+* *Valinomycin*) or simultaneously with both pIV from pGJ4 (leaky expression, no addition of IPTG) and Valinomycin (10 μM for 30 min; *MG1655* *+* *pIV* *+* *Valinomycin*). Wild-type cells expressing pIV show no apparent drop in PMF compared to MG1655~WT~ cells. CCCP and Valinomycin dissipate PMF (as seen through the marked decrease in *red* (590 nm) fluorescent cells). In addition, Psp effector proteins (induced by pIV) can not overcome the dissipation of PMF in presence of Valinomycin (Color figure online)

Paul et al*.* \[[@CR35]\] used Valinomycin and acetate (at an external pH of 5 and 7) to separate the electrical potential from the H^+^-gradient. Valinomycin is a K^+^-ionophore and specifically dissipates the electrical potential component of PMF by facilitating the influx of K^+^ into the cytoplasm whilst leaving the H^+^-gradient unchanged. Acetate in contrast disrupts the H^+^-gradient by protonating the cytoplasm after crossing the inner membrane.

Using a chromosomal ϕ*pspA*-*lacZ* reporter, the authors measured the *pspA* promoter activity in cells treated either with Valinomycin or acetate (at an external pH 5 and 7) (Fig. [1](#Fig1){ref-type="fig"}a), essentially as described by Paul et al. \[[@CR35]\]. Neither cells (primed for K^+^-uptake via Valinomycin through the addition of 150 mM KCl and 120 mM Tris to the medium) incubated with 10 μM Valinomycin for 10 or 30 min (Fig. [1](#Fig1){ref-type="fig"}a, b, c), nor cells grown in the presence of 34 mM acetate (at an external pH 5 or 7) showed any increase in activity from the *pspA* promoter (Fig. [1](#Fig1){ref-type="fig"}a). Furthermore, measurement of PMF clearly demonstrates that Valinomycin dissipates the electrical potential of the cell (MG1655 + Valinomycin; Fig. [2](#Fig2){ref-type="fig"}).

To differentiate between whether the decreased *pspA* promoter activity is due to (i) the inability of Valinomycin to induce *psp*, or (ii) because Valinomycin simply inhibits *psp* induction, cells were subjected to pIV-secretin stress in the presence of Valinomycin (Fig. [1](#Fig1){ref-type="fig"}b). In the presence of Valinomycin, pIV production caused increased *pspA* promoter activity (as measured by β-galactosidase assays) and a significant increase in PspA expression (as measured by immunoblotting with PspA specific antibodies) (Fig. [1](#Fig1){ref-type="fig"}b). Hence, Valinomycin per se does not hinder *psp* induction. The authors next measured the effect of pIV, CCCP and Valinomycin on the cell's PMF using the JC-1 dye (as described in "[Materials and Methods](#Sec2){ref-type="sec"}"). In agreement with previous reports \[[@CR25]\], pIV does not drop the PMF in wild-type cells (MG1655 + pIV, Fig. [2](#Fig2){ref-type="fig"}). It has been shown that this is due to the activated Psp response as cells lacking the activator of *psp* transcription, PspF, fail to maintain PMF at wild-type levels \[[@CR25]\]. In contrast, treatment with both CCCP (MG1655 + CCCP, Fig. [2](#Fig2){ref-type="fig"}) and Valinomycin (MG1655 + Valinomycin, Fig. [2](#Fig2){ref-type="fig"}) dissipates PMF of wild-type cells. If dissipation of PMF is the signal to activate the Psp response, then these Valinomycin treated cells should show *psp* induction. However, only CCCP induces *psp*, Valinomycin does not (Fig. [1](#Fig1){ref-type="fig"}a; Lane 2 and 6). Notably, treatment with both pIV and Valinomycin (MG1655 + pIV + Valinomycin, Fig. [2](#Fig2){ref-type="fig"}) results in PMF dissipation despite the increased activity of the *psp* promoter and production of PspA in these cells (Fig. [1](#Fig1){ref-type="fig"}b, Lane 1 vs. 4) demonstrating the Psp response is "on". Failure to maintain PMF may be because the dissipation of PMF is so severe (due to the presence of two PMF discharging agents) that Psp can not cope with it. It is also possible that Psp can not counteract the mechanism by which Valinomycin dissipates PMF (as seen with CCCP, where the induced Psp response can not maintain PMF; MG1655 + CCCP; Fig. [2](#Fig2){ref-type="fig"}).

Production of the pIV-Secretin and the Redox State of the Ubiquinone Pool {#Sec10}
-------------------------------------------------------------------------

The above data suggest that dissipation of PMF is not sufficient to induce the Psp response. Under microaerobic growth, pIV-dependent stimulation of *psp* induction requires an active ArcB \[[@CR26]\]. Activation of ArcB is responsive to the redox state of quinones---the electron carriers of the electron transport chain \[[@CR4], [@CR19], [@CR32]\]. These observations imply that quinones might play a role in the induction of the Psp response. The authors therefore determined whether the presence of the *psp* inducing stress agent, pIV-secretin, might influence the content and/or the redox state of ubiquinone and so activate ArcB (Fig. [3](#Fig3){ref-type="fig"}). The results clearly show that under aerobic and microaerobic growth pIV does influence the ubiquinone pool of the cell. The effects of pIV are much more pronounced under microaerobic growth. In cells where pIV is produced UQ~8~ is increased under microaerobic growth. UQ~8~-H~2~ is consistently decreased in the presence of pIV under aerobic and microaerobic growth. Accordingly, the redox state of ubiquinone is shifted towards the more oxidised state (with the total percentage of the reduced form UQ~8~-H~2~ being almost halved under microaerobic growth when pIV is present). Intriguingly, the effect of pIV is dependent on the activity of the Psp response (compare wild-type MG1655 cells with those lacking the ability to activate the Psp response, MG1655Δ*pspF*) (Fig. [3](#Fig3){ref-type="fig"}), and in the absence of the Psp response pIV causes an even more marked oxidation of the quinone pool. The Psp response seems to counter effects of pIV on ubiquinones.Fig. 3Ubiquinones in MG1655 and MG1655Δ*pspF* in absence (−) and presence (+) of pIV. The effect of pIV production from pGJ4 (leaky expression, no addition of IPTG) on the amount of oxidised (UQ~8~; *light grey*) and reduced (UQ~8~-H~2~; *dark grey*) ubiquinone as well as the redox state (% UQ~8~-H~2~) in wild-type MG1655 cells (with the ability to mount the Psp response) and in MG1655Δ*pspF* cells (lacking the PspF transcriptional activator, hence unable to mount the Psp response) are shown. Measurements were taken under aerobic and microaerobic growth conditions. Values for the standard deviation are included

Since pIV caused changes in the redox state of ubiquinone, a ϕ*pfl*-*lacZ* reporter fusion was used to the minimal sequence of the *pflB* promoter that is ArcBA sensitive \[[@CR38]\] to assess the impact of pIV upon ArcAB activity (Fig. [4](#Fig4){ref-type="fig"}). Differences in *pfl* promoter activity were very modest when cells with or without pIV were compared. Similar small pIV dependent differences were seen in cells lacking PspF (Fig. [4](#Fig4){ref-type="fig"}; Lane 3 and 4). The results were confirmed using a ϕ*yfiD*-*lacZ* reporter fusion to the ArcA-P dependent *yfiD* promoter (Suppl. Fig. 1). Anaerobic growth increased somewhat the *pfl* promoter activity, consistent with higher ArcB activity and hence ArcA-P levels in anaerobically grown cells (Suppl. Fig. 2). It was concluded that although the synthesis of pIV causes changes in the quinone/quinol ratio, these are insufficient to greatly impact on the amount of ArcA-P in the cells or to clearly activate ArcB for induction of the Psp response by pIV. The signal for induction of *psp* via pIV action seems not to be evident as a marked increase in ubiquinol to ubiquinone ratios. It was noted that ArcB activity is sensitive to factors other than redox state of the quinones \[[@CR4], [@CR18], [@CR20], [@CR21]\]; these could play a role in activation of the Psp response.Fig. 4Impact of pIV upon ArcAB activity. The impact of pIV upon ArcAB activity was assessed using a ϕ*pfl*--*lacZ* reporter fusion to the ArcA-P dependent *pflB* promoter (pGJ46). pIV has a modest effect on *pflB* promoter activity. Wild-type: MG1655; Δ*pspF*: MG1655Δ*pspF*; Δ*arcB*: MG1655Δ*arcB* (MVA59). pIV was under leaky expression on pGJ4 (no addition of IPTG). Cells were grown microaerobically as described in "[Material and Methods](#Sec2){ref-type="sec"}"

*psp* Induction in Electron Transport Mutants and Changes in the Ubiquinone Pool {#Sec11}
--------------------------------------------------------------------------------

In order to explore further whether changes in the quinone species or content might affect *psp* expression, the authors determined the content and redox state of ubiquinone and measured the level of *psp* induction in *E. coli* strains (EC10, EC11, EC12 and EC13; Table [1](#Tab1){ref-type="table"}) lacking either the NADH dehydrogenases NDH-1 or NDH-2 and quinol oxidases Cyt *bd*-I or Cyt *bo* \[[@CR14]\]. These components of the electron transport chain are linked by quinones, which transfer electrons from the dehydrogenases to the oxidases (Suppl. Fig. 4). Hence, the authors considered that the quinone pool of these mutants would vary significantly. Indeed, both the oxidised and reduced forms of the ubiquinones exhibited marked differences (with respect to each other), depending on which combination of dehydrogenase and oxidase was deleted, thereby enabling any correlation between the ubiquinones and *psp* induction to be addressed (Fig. [5](#Fig5){ref-type="fig"}).Fig. 5Induction of *psp* and the ubiquinone pool in the electron transport mutants. Comparison of (*Top*) the level of *psp* induction and (*Bottom*) the amount of oxidised (UQ~8~; *light grey*) and reduced (UQ~8~-H~2~; *dark grey*) ubiquinone as well as the redox state (% UQ~8~-H~2~) in wild-type EC10 and the electron transport mutants EC11, EC12 and EC13 under aerobic and microaerobic growth. Values for the standard deviation are included. Note that growth rates of EC11, EC12 and EC13 were similar to the parental strain EC10. Thus, the authors infer that there are no gross pleiotropic defects in these strains

A ϕ*pspA*-*lacZ* reporter fusion was introduced into the chromosome of each mutant and the parental RP437 strain to create EC10, EC11, EC12 and EC13 (Table [1](#Tab1){ref-type="table"}) and the activity of the *pspA* promoter measured under aerobic and microaerobic growth conditions (Fig. [5](#Fig5){ref-type="fig"}).

All electron transport mutants in addition contained a deletion of the *tsr* gene involved in chemotaxis \[[@CR14]\]. However, deletion of *tsr* alone had no effect on the induction of the Psp response when compared to the wild-type EC10 (data not shown). The observed differences in the *psp* induction levels among the electron transport mutants (see below) therefore were judged to be due to their individual differences with respect to the composition of their electron transport chain rather than any effects of the *tsr* deletion.

Compared to the wild-type control strain, EC10, all three electron transport mutants show elevated *psp* gene expression under aerobic and microaerobic growth, independent of pIV (Fig. [5](#Fig5){ref-type="fig"}). However, these levels of *psp* induction are markedly different. The *pspA* promoter is most active in the EC12 strain, with an eightfold increase of LacZ activity compared to EC10 under aerobic growth and an 18-fold increase under microaerobic growth. In contrast, *psp* induction in the EC13 strain is twofold under aerobic and sixfold under microaerobic growth in comparison to EC10. EC11 shows the lowest level of *psp* induction compared to EC10 with a twofold increase under aerobic and a fivefold increase under microaerobic growth (Fig. [5](#Fig5){ref-type="fig"}). Moreover, *psp* can still be much further induced by pIV in these mutant strains (Fig. [6](#Fig6){ref-type="fig"}). The effect of pIV appears to be additive to the basal level of *psp* induction in each strain (Fig. [6](#Fig6){ref-type="fig"}) showing that pIV alone does not fully deregulate the Psp response in the wild-type control. This is in line with previous reports suggesting that some PspA-dependent negative regulation still occurs under pIV stress conditions \[[@CR16], [@CR26]\].Fig. 6Induction of *psp* by pIV in the electron transport mutants. The ability of pIV-dependent (leaky expression of pIV from pGJ4, no addition of IPTG) induction of *psp* in the electron transport mutants was assessed under microaerobic growth. pIV appears to have an additive effect on *psp* induction dependent of the basal level of induction

The authors measured under either aerobic or microaerobic growth, the amount of ubiquinone (UQ~8~) and ubiquinol (UQ~8~-H~2~) and determined the redox state of the ubiquinone pool (% UQ~8~-H~2~). Under aerobic conditions (Fig. [5](#Fig5){ref-type="fig"}), no simple linear relationship between *psp* induction and ubiquinone or ubiquinol was observed. Under microaerobic growth, *psp* induction was inversely proportional to the amount of oxidised UQ~8~ (Fig. [5](#Fig5){ref-type="fig"}; e.g. the lower the amount of UQ~8~ the higher the level of *psp* induction). These data indicate the reduction of ubiquinone might well affect a low level Psp response (Fig. [5](#Fig5){ref-type="fig"}). However, the activating effects of pIV (Fig. [6](#Fig6){ref-type="fig"}) are much greater and seem not to be mediated by an increase in ubiquinol (Fig. [3](#Fig3){ref-type="fig"}).

The redox state of the ubiquinone pool is generally (in all strains tested) shifted towards a more reduced state under microaerobic growth (Fig. [5](#Fig5){ref-type="fig"}), consistent with the lowered respiratory flux under such conditions compared to full aerobiosis. In addition, when cells were grown microaerobically, low amounts of both demethylmenaquinone (DMK~8~) and menaquinone (MK~8~) could be detected in agreement with previous results \[[@CR3]\] (Suppl. Fig. 6). This observation is fully in line with the role of DMK~8~ and MK~8~ as the main type of quinone in *E. coli* under conditions with low aeration \[[@CR4], [@CR41], [@CR43], [@CR47]\]. Together with the observed redox states, these results indicate that the quinone measurements generated in this study are truly representative of the physiological state of the cell.

DMK~8~ and MK~8~ are not Required to Mount the Psp Response {#Sec12}
-----------------------------------------------------------

Both DMK~8~ and MK~8~ were observed under microaerobic growth, a condition where ArcB is required to activate *psp* transcription \[[@CR26]\]. Kinase activity of ArcB is inactivated by the ubiquinone and menaquinone analogues UQ~0~ and menadione, respectively \[[@CR19]\]. Furthermore, menaquinone was found to be essential for activation of the ArcB kinase under anaerobic conditions \[[@CR4]\]. It is therefore conceivable that DMK~8~ and MK~8~ play a role in *psp* induction.

The ability to induce *psp* was analysed in EC14 (Table [1](#Tab1){ref-type="table"}). These cells lack DMK~8~ and MK~8~ due to a deletion of *menA* \[[@CR28], [@CR40]\]. Notably, EC14 cells maintained the ability to mount the usual Psp response to pIV-secretin stress under anaerobic, microaerobic and aerobic growth. It therefore seems unlikely that either DMK~8~ or MK~8~ are required for any ArcB dependent *psp* induction (Fig. [7](#Fig7){ref-type="fig"}).Fig. 7Induction of *psp* in EC14 (MVA4Δ*menA*). The ability of pIV-dependent (leaky expression of pIV from pGJ4, no addition of IPTG) induction of *psp* in EC14 (Table [1](#Tab1){ref-type="table"}) lacking *menA* and hence both DMK~8~ and MK~8~ was assessed under aerobic, microaerobic and anaerobic growth. The lack of *menA* appears to have no effect on *psp* induction under the growth conditions tested. *White bars* pIV absent, *Grey bars* pIV present. Values for the standard deviation are included

The Psp Response can be Induced at Wild-Type PMF Levels {#Sec13}
-------------------------------------------------------

Edwards et al*.* \[[@CR14]\] reported no significant differences in the electrical potential of the electron transport mutants under aerobic growth when measured using tetraphenyl phosphonium (TPP^+^) in combination with a TPP^+^-sensitive electrode. The dye-based measurements of the cellular electrical potential under the growth conditions used for this study are congruent with the data reported by Edwards et al*.* \[[@CR14]\]. The electrical potential of the electron transport defective mutant strains was similar to wild-type, EC10, under both aerobic (data not shown) and microaerobic growth (Fig. [8](#Fig8){ref-type="fig"}). Recall their *psp* induction levels are markedly different (Fig. [5](#Fig5){ref-type="fig"}). This indicates that the differences in *psp* induction observed between the electron transport mutants may not be caused by a drop in PMF, fully supporting the observations where neither the dissipation of the electrical potential by Valinomycin nor the loss of the H^+^-gradient through acetate induced the Psp response (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}).Fig. 8PMF measurement in the electron transport mutants. The PMF in EC10, EC11, EC12 and EC13 was measured at mid-log phase growth using the JC-1 dye. The electron transport mutants show no marked decrease in the number of *red* (590 nm) fluorescent cells compared to the wild-type EC10 strain indicating wild-type PMF levels of EC11, EC12 and EC13 (Color figure online)

Discussion {#Sec14}
==========

Since its discovery nearly two decades ago \[[@CR7]\], the Psp response has been studied extensively. Today, much is known about its transcriptional regulation \[[@CR9], [@CR10], [@CR22], [@CR23], [@CR31], [@CR34], [@CR36]\], its degree of conservation and its incidence throughout bacteria, archaea and plants \[[@CR6], [@CR9], [@CR23], [@CR42], [@CR45]\]. Its role in maintenance of PMF \[[@CR9], [@CR23], [@CR25], [@CR29], [@CR30]\] and its relationship to bacterial pathogenicity \[[@CR9], [@CR10], [@CR23], [@CR37]\] have also been established. A variety of conditions have been found which stimulate *psp* expression, all of which appear to impair IM integrity \[[@CR9], [@CR23]\].

The precise nature of the *psp* inducing signal as well as determining how it is perceived has remained elusive. It was suggested that a common outcome of all *psp* inducing agents is the dissipation of PMF \[[@CR9], [@CR34]\]. Whether or not *psp* could be induced directly by low levels of PMF was untested. Similarly, an activating signal for ArcAB in its role in *psp* expression was not defined.

The data suggest that a drop in PMF may not be the primary signal for the Psp response. The authors used Valinomycin and/or acetate to analyse the contribution of each individual component of PMF in relation to induction of the Psp response. The outcome strongly suggests that dissipation neither of the electrical potential nor of the H^+^-gradient is sufficient to induce *psp*. Further support for this view emerges from electron transport mutants in which the PMF appeared to be similar to wild-type EC10 cells under both aerobic and microaerobic growth conditions (in agreement with reports from Edwards et al*.* \[[@CR14]\] where under aerobiosis the strains showed no major difference in PMF), the level of *psp* induction however varied significantly indicating that the Psp response can be mounted independently of a detectable reduction in the PMF level. Recent data published by Wang et al*.* \[[@CR44]\] also suggest that strong induction of PspA upon depletion of YidC could be independent of a drop in the PMF.

These findings can help to explain the apparent paradox of why the Psp response is still induced in cells producing pIV, despite measurements of the electrical potential clearly showing that PMF remains at near wild-type levels (\[[@CR25]\]; and compare Figs. [1](#Fig1){ref-type="fig"}a, [2](#Fig2){ref-type="fig"}). PMF maintenance under pIV stress can be attributed to a functioning Psp response, which is consistent with Psp's proposed role under stress \[[@CR25], [@CR29], [@CR30]\], since a drop in PMF is only evident in stressed cells where the Psp activator protein PspF is deleted (MG166Δ*pspF*). These mutant cells fail to maintain wild-type PMF in the presence of pIV \[[@CR25]\]. Recovery of PMF in wild type cells by the induced Psp effectors would, in principle, result in a loss of the inducing signal should it be the decreased PMF. These considerations imply that when inducing the Psp response pIV should cause a constant physiological change which cannot be completely relieved by Psp effectors. As suggested \[[@CR25], [@CR27]\], it is likely that multiple factors activate the Psp response; changes in physical and chemical properties of the membrane linked to change in cell physiology (see below) may serve as the *psp* inducing signal.

The data suggest that PspA content when pIV is not being expressed is inversely correlated to the amount of oxidised ubiquinone. This is also logical since ArcB is inhibited by oxidised ubiquinones. However, the higher level *psp* induction seen with pIV occurs when the oxidised ubiquinone is increasing. Thus, the requirements for ArcB activity in pIV-dependent *psp* expression cannot be explained by the quinone redox state, although other ArcB activating signals may be at play \[[@CR4], [@CR18], [@CR20], [@CR21]\]. A *psp* inducing signal elicited by pIV which is not PMF or the quinone redox state might simply rely on a relatively low and constant level of ArcA-P activity in microaerobically grown cells. In agreement, inactivation of TolC which induces *psp* also triggers a metabolic shutdown, increases the reducing capacity of the cell, inhibits NADH-I and NADH-II, and causes high NADH/NAD^+^ ratios and IM stress \[[@CR11]\]. These findings further underline the possibility that *psp* can be induced by multiple factors. Sensitivities of the electron transport chain and cellular redox towards pIV being mislocalised in the IM could elicit the primary inducing signals \[[@CR25]\].
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